MedTrace Logo

Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy

NCT04479514 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-05-01

Study results available
· View outcomes & findings →

Summary

This research study is examining a preventive skin care regimen for children diagnosed with a brain tumor and receiving anti-cancer therapy with a MEK, Pan-RAF, or BRAF inhibitor.

Conditions

  • Pediatric Cancer
  • CNS Tumor, Childhood
  • Skin Inflammation

Interventions

OTHER

Warm Baths or Showers

Daily warm baths or showers

OTHER

Moisturizer

moisturizers applied daily immediately after bathing

DRUG

SPF 30 or Higher Suncreen

Mineral based sunscreen of SPF 30 or higher applied on a daily basis on all sun exposed areas.

OTHER

Sun Protective Clothing

Sun protective clothing worn when outdoors

BEHAVIORAL

Limited Sun Exposure

Limit sun exposure during peak hours of 10am-4pm

OTHER

Dilute bleach baths

Warm 10-15 minute dilute bleach baths every other day

Sponsors & Collaborators

Principal Investigators

  • Jennifer Huang, MD · Boston Children's Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2024-01-01
Completion
2025-02-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04479514 on ClinicalTrials.gov